CSF1R and HCST: Novel Candidate Biomarkers Predicting the Response to Immunotherapy in Non-Small Cell Lung Cancer

Por Qi, Xiaoguang, Qi, Chunyan, Wu, Tao, Hu, Yi
Publicado no Technol Cancer Res Treat (2020)

Identification of candidate genes and prognostic value analysis in patients with PDL1-positive and PDL1-negative lung adenocarcinoma

Por Qi, Xiaoguang, Qi, Chunyan, Kang, Xindan, Hu, Yi, Han, Weidong
Publicado no PeerJ (2020)

Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma

Por Qi, Xiaoguang, Qi, Chunyan, Qin, Boyu, Kang, Xindan, Hu, Yi, Han, Weidong
Publicado no Front Oncol (2020)

Simple modifications to Methimazole that enhance its inhibitory effect on Tumor Necrosis Factor-α-induced Vascular Cell Adhesion Molecule-1 expression by human endothelial cells

Por Alapati, Anuja, Deosarkar, Sudhir P., Lanier, Olivia L., Qi, Chunyan, Carlson, Grady E., Burdick, Monica M., Schwartz, Frank L., McCall, Kelly D., Bergmeier, Stephen C., Goetz, Douglas J.
Publicado no Eur J Pharmacol (2015)

Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells

Por Noori, Mahboubeh S., O'Brien, John D., Champa, Zachary J., Deosarkar, Sudhir P., Lanier, Olivia L., Qi, Chunyan, Burdick, Monica M., Schwartz, Frank L., Bergmeier, Stephen C., McCall, Kelly D., Goetz, Douglas J.
Publicado no Eur J Pharmacol (2017)